June 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
In the rapidly evolving life sciences and healthcare landscape, the secure and privacy-preserving exchange and linkage of health data is …
June 18, 2024
by Andrii Buvailo
Biopharma insight
Among many important helathcare tech topics discussed at the inagural HLTH Europe 2024 conference taking place on June 17-20 in …
June 18, 2024
by Roman Kasianov
News
Basecamp Research, in collaboration with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona, has introduced ZymCTRL, an …
June 18, 2024
by Natalia Honchar
Biopharma insight
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences …
June 17, 2024
by Roman Kasianov
News
Enveda Biosciences has successfully raised $55 million in a Series B2 financing round, bringing its total capital raised to $230 …
June 17, 2024
by Andrii Buvailo, PhD
News
Yonalink, a Boston-based provider of EHR-to-EDC streaming solutions for clinical trials, has announced the successful completion of its largest live …
June 16, 2024
by Andrii Buvailo
Biopharma insight
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
June 14, 2024
by Roman Kasianov
News
Santa Ana Bio, a precision immunology company focused on developing targeted therapies for autoimmune and inflammatory diseases, has officially launched …
June 13, 2024
by Andrii Buvailo, PhD
Interview
Toronto-based “techbio” company Deep Genomics has just annouced major milestones with the opening of a new office and lab facility …
June 13, 2024
by Roman Kasianov
News
QuantumPharm, operating as XtalPi, an AI-driven drug research company from China, commenced trading on the Hong Kong Stock Exchange on …
June 12, 2024
by Roman Kasianov
News
Cytomos has introduced Celledonia, a benchtop cell analyzer that promises to transform bioprocessing by delivering near real-time, cell-specific insights. Utilizing …
June 12, 2024
by Roman Kasianov
News
Lantern Pharma Inc., an AI-driven company focused on oncology drug development, has announced that the Japan Patent Office (JPO) has granted …